Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 57 (HNRNPA1P57) is a pseudogene—a non-functional DNA sequence derived from the functional HNRNPA1 gene, which encodes a well-studied RNA-binding protein involved in RNA metabolism and associated with several disease states, especially cancers[1][3][5]. Like most pseudogenes, HNRNPA1P57 does not encode a protein and is generally not considered an active participant in biological processes or disease mechanisms[1][3][5]. There is currently no evidence that HNRNPA1P57 has direct biological function, clinical significance, or relevance as a therapeutic target, biomarker, or drug interaction site. Its parent gene, HNRNPA1, is functionally and clinically important, but HNRNPA1P57 itself should not be mistaken for a protein-coding gene or a valid molecular target[1][3][5]. Additional context: - Pseudogenes are sometimes expressed at the RNA level and may play a role in gene regulation or disease, but there is no current evidence that HNRNPA1P57 serves such a function[5]. - The gene is listed in gene databases (e.g., GeneCards, BioGPS) as a pseudogene with no assigned protein product or drug interactions[1][3]. - If your workflow requires recognized/active targets, HNRNPA1P57 should not be treated as such. HNRNPA1P57 is not a molecular target, receptor, enzyme, or biomedically recognized classification and should not be considered for therapeutic, diagnostic, or biomarker applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 57 (HNRNPA1P57).